Antibody fragments, expressed by a fowl adenovirus vector, are able to neutralize infectious bursal disease virus

Avian Pathology

Volumn 39, Issue 5, 2010, Pages 339-348

  Greenall, Sameer A ^a,b   Tyack, Scott G ^a   Johnson, Michael A ^a   Sapats, Sandra I ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FRAGMENT; VIRUS ANTIBODY;

ANIMAL; ARTICLE; AVIADENOVIRUS; CELL LINE; CHICKEN; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE VECTOR; GENETICS; IMMUNOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; METABOLISM; PLASMID; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; AVIADENOVIRUS; CELL LINE; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENETIC VECTORS; IMMUNOGLOBULIN FRAGMENTS; INFECTIOUS BURSAL DISEASE VIRUS; PLASMIDS; VIRUS REPLICATION;

ADENOVIRIDAE; INFECTIOUS BURSAL DISEASE VIRUS; SPONDIAS PURPUREA;

EID: 77958160087     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079457.2010.507239     Document Type: Article

References (43)

1. Afanasieva, T.A., Wittmer, M., Vitaliti, A., Ajmo, M., Neri, D. & Klemenz, R. (2003). Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy. Gene Therapy, 10, 1850-1859.
2. Borsi, L., Balza, E., Bestagno, M., Castellani, P., Carnemolla, B., Biro, A., et al. (2002). Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. International Journal of Cancer, 102, 75-85.
3. Carette, J.E., Graat, H.C., Schagen, F.H., Abou El Hassan, M.A., Gerritsen, W.R. & van Beusechem, V.W. (2005). Replicationdependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site. Journal of Gene Medicine, 7, 1053-1062.
4. Cherenova, L.V., Logunov, D.Y., Shashkova, E.V., Shmarov, M.M., Verkhovskaya, L.V., Neugodova, G.L., et al. (2004). Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo. Virus Research, 100, 257-261.
5. Cochet, O., Kenigsberg, M., Delumeau, I., Virone-Oddos, A., Multon, M.C., Fridman, W.H., et al. (1998). Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. Cancer Research, 58, 1170-1176.
6. de Wilt, J.H., Bout, A., Eggermont, A.M., van Tiel, S.T., de Vries, M.W., ten Hagen, T.L., et al. (2001). Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats. Human Gene Therapy, 12, 489-502.
7. Esandi, M.C., van Someren, G.D., Vincent, A.J., van Bekkum, D.W., Valerio, D., Bout, A. & Noteboom, J.L. (1997). Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Therapy, 4, 280-287.
8. Fahey, K.J., McWaters, P., Brown, M.A., Erny, K., Murphy, V.J. & Hewish, D.R. (1991). Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens. Avian Diseases, 35, 365-373.
9. Firth, G.A. (1974). Letter: Occurrence of an infectious bursal syndrome within an Australian poultry flock. Australian Veterinary Journal, 50, 128-130.
10. Francois, A., Chevalier, C., Delmas, B., Eterradossi, N., Toquin, D., Rivallan, G. & Langlois, P. (2004). Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens. Vaccine, 22, 2351-2360.
11. Goel, A., Colcher, D., Baranowska-Kortylewicz, J., Augustine, S., Booth, B.J., Pavlinkova, G. & Batra, S.K. (2000). Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application. Cancer Research, 60, 6964-6971.
12. Goossens, P.H., Schouten, G.J., Heemskerk, B.,'t Hart, B.A., Bout, A., Kluin, P.M., et al. (2000). The effect of promoter strength in adenoviral vectors in hyperplastic synovium. Clinical Experimental Rheumatology, 18, 547-552.
13. Ignjatovic, J., Gould, G., Trinidad, L. & Sapats, S. (2006). Chicken recombinant antibodies against infectious bursal disease virus are able to form antibody-virus immune complex. Avian Pathology, 35, 293-301.
14. Jendreyko, N., Rader, C., Barbas, C.F. & Gaedicke, G. (2006). Simultaneous, phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody enhances antiangiogenic effects in vivo. Klinische Pädiatrie, 218, 143-151.
15. Jessup, C.F., Brereton, H.M., Coster, D.J. & Williams, K.A. (2005a). In vitro adenovirus mediated gene transfer to the human cornea. British Journal of Ophthalmology, 89, 658-661.
16. Jessup, C.F., Brereton, H.M., Sykes, P.J., Thiel, M.A., Coster, D.J. & Williams, K.A. (2005b). Local gene transfer to modulate rat corneal allograft rejection. Investigative Ophthalmology and Visual Science, 46, 1675-1681.
17. Johnson, M.A., Pooley, C. & Lowenthal, J.W. (2000). Delivery of avian cytokines by adenovirus vectors. Developmental and Comparative Immunology, 24, 343-354.
18. Johnson, M.A., Pooley, C., Ignjatovic, J. & Tyack, S.G. (2003). A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus. Vaccine, 21, 2730-2736.
19. Kramer, R.A., Marissen, W.E., Goudsmit, J., Visser, T.J., Clijsters-Van der Horst, M., Bakker, A.Q., et al. (2005). The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. European Journal of Immunology, 35, 2131-2145.
20. Le Goff, F., Mederle-Mangeot, I., Jestin, A. & Langlois, P. (2005). Deletion of open reading frames 9, 10 and 11 from the avian adenovirus CELO genome: effect on biodistribution and humoral responses. Journal of General Virology, 86, 2019-2027.
21. ΔΔCT method. Methods, 25, 402-408.
22. Long, M.C., Marshall, K.E., Kearney, B.J., Ludwig, G.V., Wong, J.P. & Nagata, L.P. (2001). Pharmacokinetics study of a novel chimeric single-chain variable fragment antibody against western equine encephalitis virus. Hybridoma, 20, 1-10.
23. Maynard, J.A., Maassen, C.B., Leppla, S.H., Brasky, K., Patterson, J.L., Iverson, B.L. & Georgiou, G. (2002). Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nature Biotechnology, 20, 597-601.
24. Michou, A.I., Lehrmann, H., Saltik, M. & Cotton, M. (1999). Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. Journal of Virology, 73, 1399-1410.
25. Muller, B.H., Lafay, F., Demangel, C., Perrin, P., Tordo, N., Flamand, A., et al. (1997). Phage-displayed and soluble mouse scFv fragments neutralize rabies virus. Journal of Virological Methods, 67, 221-233.
26. Ojkic, D. & Nagy, E. (2003). Antibody response and virus tissue distribution in chickens inoculated with wild-type and recombinant fowl adenoviruses. Vaccine, 22, 42-48.
27. Ono, K., Kamihira, M., Kuga, Y., Matsumoto, H., Hotta, A., Itoh, T., et al. (2003). Production of anti-prion scFv-Fc fusion proteins by recombinant animal cells. Journal of Bioscience and Bioengineering, 95, 231-238.
28. Popkov, M., Jendreyko, N., McGavern, D.B., Rader, C. & Barbas, C.F., 3rd (2005). Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. Cancer Research, 65, 972-981.
29. Powers, D.B., Amersdorfer, P., Poul, M., Nielsen, U.B., Shalaby, M.R., Adams, G.P., et al. (2001). Expression of single-chain Fv-Fc fusions in Pichia pastoris. Journal of Immunological Methods, 251, 123-135.
30. Rauw, F., Lambrecht, B., Francois, A., Langlois, P. & van den Berg, T. (2007). Kinetic and biologic properties of recombinant ChIFNgamma expressed via CELO-virus vector. Journal of Interferon Cytokine Research, 27, 111-118.
31. Ray, K., Embleton, M.J., Jailkhani, B.L., Bhan, M.K. & Kumar, R. (2001). Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1. Clinical and Experimental Immunology, 125, 94-101.
32. Reynaud, C.A., Anquez, V., Dahan, A. & Weill, J.C. (1985). A single rearrangement event generates most of the chicken immunoglobulin light chain diversity. Cell, 40, 283-291.
33. Sallenave, J.M., Xing, Z., Simpson, A.J., Graham, F.L. & Gauldie, J. (1998). Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters. Gene Therapy, 5, 352-360.
34. Sambrook, Jr, D. (2001). Molecular Cloning: A Laboratory Manual 3rd edn. New York: Cold Spring Harbour Laboratory Press.
35. Sapats, S.I., Heine, H.G., Trinidad, L., Gould, G.J., Foord, A.J., Doolan, S.G., et al. (2003). Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV). Archives of Virology, 148, 497-515.
36. Shashkova, E.V., Cherenova, L.V., Kazansky, D.B. & Doronin, K. (2005). Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors. Cancer Gene Therapy, 12, 617-626.
37. Sheppard, M., Werner, W., Tsatas, E., McCoy, R., Prowse, S. & Johnson, M. (1998). Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Archives of Virology, 143, 915-930.
38. Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L.J., Wong, S.K., et al. (2004). Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proceedings of the National Academy Sciences of the USA, 101, 2536-2541.
39. Sullivan, D.E., Mondelli, M.U., Curiel, D.T., Krasnykh, V., Mikheeva, G., Gaglio, P., et al. (2002). Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus nonstructural 3 protein. Journal of Hepatology, 37, 660-668.
40. van Etten, B., ten Hagen, T.L., de Vries, M.R., Ambagtsheer, G., Huet, T. & Eggermont, A.M. (2002). Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras. British Journal of Cancer, 86, 436-442.
41. Verma, R., Boleti, E. & George, A.J. (1998). Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. Journal of Immunological Methods, 216, 165-181.
42. Vincent, A.J., Esandi, M.C., Avezaat, C.J., Vecht, C.J., Sillevis Smitt, P., van Bekkum, D.W., et al. (1997). Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. Neurosurgery, 41, 451-452.
43. Yuan, W. & Parrish, C.R. (2000). Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibodycombining site and mechanisms of neutralization. Virology, 269, 471-480.